Inactive

Bupa Arabian Ventures

Investor type

VC

Founded

1997

AUM

-

Location

Jeddah, Mecca, Saudi Arabia

Investment Ticket

$0-1 m

Investment Stage

Series B Series A Seed Pre-seed Late Stage (Series C+)

Region of investment

Middle East
Investor profile last updated: 30 August, 2026

Profile

Bupa Arabian Ventures is a venture capital firm based in Saudi Arabia. Founded as a subsidiary of Bupa Arabia, the firm specializes in investing in the healthcare sector. The team consists of experienced professionals with backgrounds in healthcare management and corporate finance. Bupa Arabian Ventures distinguishes itself by focusing on innovation within the healthcare industry, aiming to support startups that bring new solutions to the market.

Bupa Arabian Ventures invests primarily in the healthcare sector. It focuses on businesses that provide healthcare services, develop medical devices, or offer digital health solutions. The firm typically invests in early to growth-stage companies within the Middle East region. As of now, specific fund details and total assets under management are not publicly disclosed.

Their notable investments include companies such as Altibbi - a digital health platform, and Vezeeta - an online healthcare scheduling service. These investments reflect their strategy to enhance and broaden access to healthcare services within the region.

Industry

HealthTech Life Sciences Pharmaceuticals Medical Devices Healthcare Services Digital Biotechnology

Contacts

Name
Title
Email
avatar
Tal Hisham Nazer CEO
CEO
-
avatar
Naif Abduljawad Investment Operations Manager
Investment Operations Manager
-
Upgrade to see contacts
avatar
OxuKcot1SHLpMa2C OxuKcot1SHLpMa2C
OxuKcot1SHLpMa2C
avatar
OxuKcot1SHLpMa2C OxuKcot1SHLpMa2C
OxuKcot1SHLpMa2C
avatar
OxuKcot1SHLpMa2C OxuKcot1SHLpMa2C
OxuKcot1SHLpMa2C
Investment-team contacts for Bupa Arabian Ventures — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Bupa Arabian Ventures

Bupa Arabian Ventures is a venture capital firm. It backs companies at Series B, Series A, Seed, Pre-seed and Late Stage (Series C+), writing tickets of $0-1 m.
Bupa Arabian Ventures is located in Jeddah, Mecca, Saudi Arabia.
Bupa Arabian Ventures was founded in 1997.
Bupa Arabian Ventures invests in companies and startups in HealthTech, Life Sciences, Pharmaceuticals, Medical Devices, Healthcare Services, Digital, Biotechnology.
Bupa Arabian Ventures invests in companies and startups in Middle East.
Bupa Arabian Ventures invests in companies and startups at Series B, Series A, Seed, Pre-seed, Late Stage (Series C+).
Bupa Arabian Ventures usually invests $0-1 m on average.
Bupa Arabian Ventures can be reached through its website bupa.com.sa, its LinkedIn page and its X account. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Bupa Arabian Ventures — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Bupa Arabian Ventures directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 30 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.